RMR Wealth Builders’s Anavex Life Sciences AVXL Stock Holding History

RMR Wealth Builders’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250	Closed	-$4K	–	217
2021 Q1	$4K	Buy	+250	New	+$2.73K	﹤0.01%	685

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

GLA

Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RMR Wealth Builders's AVXL Position: Q2 2021 in Review

RMR Wealth Builders sold out of Anavex Life Sciences (AVXL) in Q2 2021, closing a stake of 250 shares — an estimated $4K sold.

RMR Wealth Builders first reported a position in AVXL in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 127 funds tracked by Wall St. Rank hold AVXL as of Q2 2021.

RMR Wealth Builders reported no remaining Anavex Life Sciences position as of Q2 2021 after selling out during the quarter.
RMR Wealth Builders sold 250 Anavex Life Sciences shares in Q2 2021, an estimated $4K.
RMR Wealth Builders first reported a position in Anavex Life Sciences in Q1 2021 and held it in 1 quarter.
RMR Wealth Builders's Anavex Life Sciences position peaked at $4K in Q1 2021.
127 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.